LIMNW Liminatus Pharma, Inc.
Fundamentals / CIK 0001971387 / USDLiminatus Pharma, Inc. reported $3.40M in total assets and a net loss of $12.52M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LIMNW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$4.07M Operating profit
-
Net Income FY 2025-$12.52M GAAP bottom line
-
Diluted EPS FY 2025-$0.26 Split-adjusted
-
Free Cash Flow FY 2025-$9.98M Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$3.02M Total debt: $1.44M
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Research & Development | -- | $2.69M |
| Total Operating Expenses | $2.97M | $3.33M |
| Operating Income | -$2.97M | -$3.33M |
| EBITDA | -$2.97M | -- |
| Interest Income | $77K | $123K |
| Interest Expense | $216K | $339K |
| Net Income | -$10.21M | -$3.55M |
| Basic EPS | -$0.43 | -$0.20 |
| Diluted EPS | -$0.43 | -$0.20 |
| Basic Shares Outstanding | 23.8M | 17.5M |
| Diluted Shares Outstanding | 23.8M | 17.5M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $600K | $400K | -- | -- | -- | -- | -- | $357K |
| Total Operating Expenses | $1.38M | $1.10M | $884K | $701K | $1.12M | $264K | -- | $543K |
| Operating Income | -$1.38M | -$1.10M | -$884K | -$701K | -$1.12M | -$264K | -$167K | -$543K |
| EBITDA | -$1.38M | -$1.10M | -- | -- | -- | -- | -- | -- |
| Interest Income | -- | -- | $0 | $0 | $24K | $52K | -- | $34K |
| Interest Expense | $19K | $19K | $19K | $19K | $62K | $116K | -- | $93K |
| Net Income | -$1.41M | -$1.12M | -$8.17M | -$1.82M | $113K | -$328K | -$230K | -$601K |
| Basic EPS | -$0.03 | -$0.03 | -- | -$0.07 | $0.00 | -$0.02 | -- | -$0.03 |
| Diluted EPS | -$0.03 | -$0.03 | -- | -$0.07 | $0.00 | -$0.02 | -- | -$0.03 |
| Basic Shares Outstanding | 48.4M | 36.0M | -- | 27.0M | 23.3M | 17.5M | -- | 17.5M |
| Diluted Shares Outstanding | 48.4M | 36.0M | -- | 27.0M | 23.3M | 17.5M | -- | 17.5M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $338K | $56K |
| Cash & Short-Term Investments | $338K | $56K |
| Total Current Assets | $501K | $5.28M |
| Property, Plant & Equipment, Net | $12K | $941 |
| Total Non-Current Assets | $12K | $127K |
| Total Assets | $513K | $5.41M |
| Short-Term Debt | $1.44M | $19.97M |
| Total Current Liabilities | $10.30M | $24.75M |
| Total Non-Current Liabilities | $29K | $0 |
| Total Liabilities | $10.33M | $24.75M |
| Total Debt (incl. Leases) | $1.44M | $19.97M |
| Common Stock | $2.7K | $1.8K |
| Retained Earnings | -$38.87M | -$28.67M |
| Total Stockholders' Equity | -$9.81M | -$19.34M |
| Total Equity | -$9.81M | -$19.34M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.02M | $1.91M | $338K | $725K | $1.34M | $56K |
| Cash & Short-Term Investments | $3.02M | $1.91M | $338K | $725K | $1.34M | $56K |
| Total Current Assets | $3.39M | $2.78M | $501K | $1.20M | $1.78M | $5.28M |
| Property, Plant & Equipment, Net | $11K | $12K | $12K | $13K | $198 | $941 |
| Total Non-Current Assets | $11K | $12K | $12K | $139K | $126K | $127K |
| Total Assets | $3.40M | $2.79M | $513K | $1.34M | $1.91M | $5.41M |
| Short-Term Debt | $1.44M | $1.44M | $1.44M | $1.44M | $1.44M | $19.97M |
| Total Current Liabilities | $3.04M | $2.89M | $10.30M | $2.86M | $10.52M | $24.75M |
| Total Non-Current Liabilities | $63K | $33K | $29K | $124K | $200K | $0 |
| Total Liabilities | $3.10M | $2.92M | $10.33M | $2.99M | $10.72M | $24.75M |
| Total Debt (incl. Leases) | $1.44M | $1.44M | $1.44M | $1.44M | $1.44M | $19.97M |
| Common Stock | $5.6K | $4.8K | $2.7K | $2.7K | $2.6K | $1.8K |
| Retained Earnings | -$41.40M | -$40.00M | -$38.87M | -$30.70M | -$28.88M | -$28.67M |
| Total Stockholders' Equity | $301K | -$133K | -$9.81M | -$1.65M | -$8.81M | -$19.34M |
| Total Equity | $301K | -$133K | -$9.81M | -$1.65M | -$8.81M | -$19.34M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$10.21M | -$3.55M |
| Depreciation & Amortization | $1.8K | -- |
| Operating Cash Flow | -$9.96M | -$1.45M |
| Capital Expenditure | -$13K | -- |
| Free Cash Flow | -$9.98M | -- |
| Investing Cash Flow | -$788K | -$2.85M |
| Financing Cash Flow | $11.03M | $3.92M |
| Net Change in Cash | $281K | -$378K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.41M | -$1.12M | -$8.17M | -$1.82M | $113K | -$328K | -$230K | -$601K |
| Depreciation & Amortization | $468 | $518 | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow | -$970K | -$2.02M | -$387K | -$601K | -$8.82M | -$159K | -$141K | -$206K |
| Investing Cash Flow | -- | -- | $0 | -$13K | -$200K | -$575K | -- | -- |
| Financing Cash Flow | $2.08M | $3.59M | $0 | $0 | $10.32M | $713K | -- | -- |
| Net Change in Cash | $1.11M | $1.57M | -$387K | -$614K | $1.30M | -$21K | $9.3K | $13K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Return on Assets (ROA) | -1990.4% | -65.6% |
| Current Ratio | 0.05x | 0.21x |
| Quick Ratio | 0.03x | 0.00x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -4165.9% | -- | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -367.9% | -394.3% | -1990.4% | -168.9% | -54.8% | -- | -65.6% | -- |
| Current Ratio | 1.12x | 0.96x | 0.05x | 0.42x | 0.17x | -- | 0.21x | -- |
| Quick Ratio | 0.99x | 0.66x | 0.03x | 0.25x | 0.13x | -- | 0.00x | -- |
| Debt to Equity | 4.80x | -- | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -1342.2% | -- | -- | -- | -- | -- | -- | -- |